Best practice tips for selecting a prepared media supplier

11 Feb 2018

What does a good supplier look like? Andrew Ramage, Microbiology Product Specialist at Cherwell Laboratories, advises how to take the guesswork out of the search.

Any businesses requiring prepared media for microbiological testing activities, such as environmental monitoring, need to know two things: that all media is guaranteed to be of high quality and offer reliable results; and that confidence in the supplier is rooted in provable standards, certifications and validated processes.

Best practice tips for selecting a prepared media supplier

Researching potential suppliers is, of course, essential, but where do you start with understanding what a good supplier looks like? There are many factors to consider - from their media manufacture processes, storage and transport to their depth of technical knowledge, and the kind of relationship you can expect to nurture.

Best practice tips for finding suppliers:

  • Aim to narrow your field of search quickly to eliminate bad fit suppliers.
  • Write a ‘wish list’ of qualities you want from your ideal supplier; for example, good customer service that is responsive to your requests or concerns, can offer flexibility in their service and can offer bespoke solutions.
  • Rather than asking open-ended questions, be as specific as possible to minimise the process timescale.
  • Be clear about your own business needs - how frequently you require deliveries etc. Suppliers can’t give an honest idea of prices and service levels if you’re fuzzy about what you need.
  • Once you have your own criteria mapped out, here are the key questions for your shortlisted potential suppliers:

  • What is their quality control system for guaranteed media reliability?
  • What technical knowledge of cleanroom procedures do they possess?
  • Are they willing to go the extra mile to meet your needs?
  • Can they display a proven track record?
  • Can you take a tour of their facilities and meet the team?
  • Cherwell Laboratories, specialist suppliers of products for environmental monitoring and process validation, has published an eBook: The Pharmaceutical and Cleanroom Industry’s Pocket Guide to Prepared Culture Media. The guide, which is intended for anyone involved in using and/or buying microbiological media, aims to provide an understanding of the best practices and breadth of prepared culture media options for varying applications within the pharmaceutical and cleanroom industry.

    The comprehensive guide equips the reader with all the information they need to consider in order to produce; purchase; store and use prepared media effectively. Focusing on the key topics covered in the guide will help readers to ensure their culture media is of a consistently high quality to deliver reliable results that they can be confident of, every time.

    Topics within the guide include: an overview of the various applications of prepared media; best practice guidelines for handling and storing prepared media; the logistics of in-house prepared media manufacture; the argument for pre-prepared media versus in-house manufacturing and guidelines on how to choose a prepared media supplier.

    Commenting on the eBook, Andrew Ramage says: “I hope this booklet will educate and inform the reader of the many considerations needed to manufacture high-quality microbiological growth media. A flexible and reliable manufacturer of prepared media will be able to guarantee the customer receives exactly the product they require, to a consistently high standard. Once the reader has finished reading this booklet they should also have a clearer understanding of the pros and cons of buying in prepared media versus manufacturing in-house.”

    Read More

    Related tags

    Top Stories Market News

    Related news

    BMS and Celgene merge to create premier innovative biopharma company

    BMS and Celgene merge to create premier innovative biopharma company

    3 Jan 2019

    Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential.

    Read more 
    An increased risk of a hard or ‘no deal Brexit?

    An increased risk of a hard or ‘no deal Brexit?

    24 Dec 2018

    A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business.

    Read more 
    One month on: medical cannabis is still taboo despite change in law

    One month on: medical cannabis is still taboo despite change in law

    11 Dec 2018

    Restrictive guidelines have led many to buy CBD products online, leading to a boom in production with many products going to market without sufficient quality control.

    Read more 
    EU FMD - time is running out!

    EU FMD - time is running out!

    13 Nov 2018

    Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches.

    Read more 
    Proprietary nasal delivery formulation of diazepam reaches NDA

    Proprietary nasal delivery formulation of diazepam reaches NDA

    7 Nov 2018

    The absolute bioavailability of the Valtoco intranasal formulation was 96% of intravenous diazepam in a Phase I cross-over trial.

    Read more 
    DSCSA one-month countdown!

    DSCSA one-month countdown!

    30 Oct 2018

    With only a month to go, it really is too late to start trying to develop an in-house solution.

    Read more 
    Global pharma set for strong year

    Global pharma set for strong year

    23 Oct 2018

    Eight of the top ten pharma nations reporting improving market conditions.

    Read more 
    Generics companies to move away from little white pills

    Generics companies to move away from "little white pills"

    14 Oct 2018

    Accepting more complexity and risk is key for those generics companies seeking competitive differentiation by diversifying their product portfolios.

    Read more 
    CMOs to benefit from double digit approvals for ADCs in the next 3 years

    CMOs to benefit from double digit approvals for ADCs in the next 3 years

    9 Oct 2018

    Therapeutic ADC market expected to reach $4 billion by 2023.

    Read more 
    Movement on the market reflected at CPhI Worldwide 2018

    Movement on the market reflected at CPhI Worldwide 2018

    3 Oct 2018

    Companies new to CPhI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives.

    Read more